Jeffrey Wang

2.1k total citations
76 papers, 1.5k citations indexed

About

Jeffrey Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jeffrey Wang has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Jeffrey Wang's work include Drug Transport and Resistance Mechanisms (8 papers), Curcumin's Biomedical Applications (8 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). Jeffrey Wang is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Curcumin's Biomedical Applications (8 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). Jeffrey Wang collaborates with scholars based in United States, China and Canada. Jeffrey Wang's co-authors include Sunil Prabhu, Arvind Thakkar, Zhijun Wang, Guru V. Betageri, Andrew S. Pumerantz, Ying Huang, Preshita Desai, Dhruvitkumar S. Sutaria, Wei‐Chiang Shen and David K. Ann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jeffrey Wang

73 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Wang United States 21 552 220 181 170 141 76 1.5k
Shweta Shrivastava India 20 562 1.0× 171 0.8× 117 0.6× 134 0.8× 118 0.8× 49 1.4k
Ashish Baldi India 20 692 1.3× 223 1.0× 248 1.4× 114 0.7× 111 0.8× 135 1.8k
Xue Li China 21 582 1.1× 110 0.5× 139 0.8× 161 0.9× 109 0.8× 85 1.4k
Usama A. Fahmy Saudi Arabia 24 459 0.8× 286 1.3× 542 3.0× 130 0.8× 86 0.6× 84 1.7k
Hani Z. Asfour Saudi Arabia 24 534 1.0× 139 0.6× 191 1.1× 78 0.5× 71 0.5× 82 1.4k
Connie M. Remsberg United States 18 633 1.1× 234 1.1× 104 0.6× 154 0.9× 56 0.4× 41 1.9k
Shyr-Yi Lin Taiwan 27 813 1.5× 117 0.5× 86 0.5× 179 1.1× 87 0.6× 60 1.6k
Irene Iglesias Peinado Spain 26 523 0.9× 186 0.8× 91 0.5× 135 0.8× 244 1.7× 85 2.2k
Ankit Awasthi India 26 408 0.7× 155 0.7× 294 1.6× 62 0.4× 111 0.8× 70 1.6k
Snehal Patel India 25 534 1.0× 126 0.6× 165 0.9× 108 0.6× 236 1.7× 109 2.3k

Countries citing papers authored by Jeffrey Wang

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Wang more than expected).

Fields of papers citing papers by Jeffrey Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Wang. The network helps show where Jeffrey Wang may publish in the future.

Co-authorship network of co-authors of Jeffrey Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Wang. A scholar is included among the top collaborators of Jeffrey Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Wang. Jeffrey Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Patrick P. K., et al.. (2024). Impact of bariatric surgery on cytochrome P 450 enzyme activity. Frontiers in Pharmacology. 15. 1372950–1372950. 1 indexed citations
2.
Shamim, Abdullah, Ayaz Shahid, Steven Yeung, et al.. (2023). Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention. Nanomaterials. 13(5). 929–929. 16 indexed citations
3.
Karimzadeh, Mehran, Jeffrey Wang, Alice Huang, et al.. (2023). Abstract 5711: Blood-based early detection of non-small cell lung cancer using orphan noncoding RNAs. Cancer Research. 83(7_Supplement). 5711–5711. 1 indexed citations
4.
Andresen, Bradley T., Ayaz Shahid, Jeffrey Wang, et al.. (2023). Recent Advances in Clinical Research for Skin Cancer Chemoprevention. Cancers. 15(15). 3819–3819. 8 indexed citations
5.
Morrissey, Ian, Meng Xiao, Tianshu Sun, et al.. (2022). In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China. Infection and Drug Resistance. Volume 15. 2101–2113. 6 indexed citations
6.
Desai, Preshita, et al.. (2020). Efficacy and Pharmacokinetic Considerations of Loratadine Nanoformulations and its Combinations for Pancreatic Cancer Chemoprevention. Pharmaceutical Research. 37(2). 21–21. 9 indexed citations
7.
Wang, Jeffrey, Jeffrey R. Strich, Junfeng Sun, et al.. (2020). Driving blind: instituting SEP-1 without high quality outcomes data. Journal of Thoracic Disease. 12(S1). S22–S36. 18 indexed citations
8.
Desai, Preshita, et al.. (2020). Cancer Chemoprevention Using Nanotechnology-Based Approaches. Frontiers in Pharmacology. 11. 323–323. 17 indexed citations
9.
Wang, Jeffrey, et al.. (2019). Tumor Lysis Syndrome Associated with UrothelialCancer: A Case Series. 1(3). 1–3. 1 indexed citations
10.
11.
Desai, Preshita, David K. Ann, Jeffrey Wang, & Sunil Prabhu. (2018). Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies. Critical Reviews in Therapeutic Drug Carrier Systems. 36(1). 59–91. 17 indexed citations
12.
Wang, Zhijun, Bogdan Olenyuk, Jean C. Shih, & Jeffrey Wang. (2017). Quantification and pharmacokinetic study of tumor-targeting agent MHI148-clorgyline amide in mouse plasma using liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical Analysis. 8(3). 153–159. 4 indexed citations
13.
Jackevicius, Cynthia A., Jennifer Lê, Lama Nazer, et al.. (2014). A Formal Mentorship Program for Faculty Development. American Journal of Pharmaceutical Education. 78(5). 100–100. 60 indexed citations
14.
Thakkar, Arvind, et al.. (2013). A Novel Combinatorial Nanotechnology-Based Oral Chemopreventive Regimen Demonstrates Significant Suppression of Pancreatic Cancer Neoplastic Lesions. Cancer Prevention Research. 6(10). 1015–1025. 33 indexed citations
15.
Sutaria, Dhruvitkumar S., et al.. (2012). Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. International Journal of Oncology. 41(6). 2260–2268. 56 indexed citations
16.
Chaudhary, Abhishek, Dhruvitkumar S. Sutaria, Ying Huang, Jeffrey Wang, & Sunil Prabhu. (2011). Chemoprevention of Colon Cancer in a Rat Carcinogenesis Model Using a Novel Nanotechnology-Based Combined Treatment System. Cancer Prevention Research. 4(10). 1655–1664. 20 indexed citations
17.
Shah, Tariq, Jae Wook Yang, Yasir Qazi, et al.. (2010). The Pharmacokinetics of Enteric-Coated Mycophenolate Sodium and Its Gastrointestinal Side Effects in De Novo Renal Transplant Recipients of Hispanic Ethnicity. Therapeutic Drug Monitoring. 33(1). 45–49. 8 indexed citations
18.
Pumerantz, Andrew S., Sunil A. Agnihotri, Carlos Guerra, et al.. (2010). Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents. 37(2). 140–144. 78 indexed citations
19.
Lien, Eric J., Linda L. Lien, & Jeffrey Wang. (2010). Longevity Depends on a Balance Between Proinflammatory and Anti-Inflammatory Factors: Use of Tcms and Natural Products. Current Drug Discovery Technologies. 7(1). 13–21. 6 indexed citations
20.
Wang, Jeffrey, Jia‐Long Fang, Xin Gao, et al.. (2008). Pharmacogenomics Approach Reveals MRP1 (ABCC1)-Mediated Resistance to Geldanamycins. Pharmaceutical Research. 26(4). 936–945. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shweta Shrivastava Breakdown of academic impact, for papers by Ashish Baldi Breakdown of academic impact, for papers by Xue Li Breakdown of academic impact, for papers by Usama A. Fahmy Breakdown of academic impact, for papers by Hani Z. Asfour Breakdown of academic impact, for papers by Connie M. Remsberg Breakdown of academic impact, for papers by Shyr-Yi Lin Breakdown of academic impact, for papers by Irene Iglesias Peinado Breakdown of academic impact, for papers by Ankit Awasthi Breakdown of academic impact, for papers by Snehal Patel
Rankless by CCL
2026